Computational framework for targeted high-coverage sequencing based NIPT

Abstract

Non-invasive prenatal testing (NIPT) enables accurate detection of fetal chromosomal trisomies. The majority of existing computational methods for sequencing-based NIPT analyses rely on low-coverage whole-genome sequencing (WGS) data and are not applicable for targeted high-coverage sequencing data from cell-free DNA samples.\n\nHere, we present a novel computational framework for a targeted high-coverage sequencing based NIPT analysis. The developed methods use a hidden Markov model (HMM)-based approach in conjunction with supplemental machine learning methods, such as decision tree (DT) and support vector machine (SVM), to detect fetal trisomy and parental origin of additional fetal chromosomes. These methods were tested with simulated datasets covering a wide range of biologically relevant scenarios with various chromosomal quantities, parental origins of extra chromosomes, fetal DNA fractions and sequencing read depths. Consequently, we determined the functional feasibility and limitations of each proposed approach and demonstrated that read count-based HMM achieved the best overall classification accuracy of 0.89 for detecting fetal euploidies and trisomies. Furthermore, we show that by using the DT and SVM methods on the HMM state classification results, it was possible to increase the final trisomy classification accuracy to 0.98 and 0.99, respectively.\n\nWe demonstrated that read count and allelic ratio-based models can achieve a high accuracy (up to 0.98) for detecting fetal trisomy even if the fetal fraction is as low as 2%. Currently existing methods require at least 4% fetal fraction, which can be an issue in the case of early gestational age (35 kg/m2). More accurate detection can be achieved at higher sequencing depth using HMM in conjunction with supplemental methods, which significantly improve the trisomy detection especially in borderline scenarios (e.g., very low fetal fraction) and can enable to perform NIPT even earlier than 10 weeks of pregnancy.